Filter
481
Filtered Results: 481
Text search:
Jacob,
N.
Featured
Recommendations
62
New Publications
77
Language
Document type
No document type
249
Studies & Reports
106
Guidelines
75
Manuals
26
Fact sheets
10
Strategic & Response Plan
8
Training Material
6
Resource Platforms
1
Countries / Regions
Global
19
Germany
14
Latin America and the Carribbean
11
Western and Central Europe
11
Brazil
11
South Africa
10
Russia
9
India
9
Eastern Europe
7
Liberia
7
Zambia
6
Ukraine
5
Syria
5
Sierra Leone
4
Rwanda
4
Mozambique
4
Africa
4
Cambodia
4
Middle East and North Africa
4
Uganda
4
Colombia
3
Kenya
3
Ghana
3
Nigeria
3
Peru
3
Haiti
3
Asia
3
West and Central Africa
3
Yemen
3
South Sudan
3
Chile
2
Senegal
2
Burkina Faso
2
Malawi
2
Zimbabwe
2
USA
2
Guinea-Bissau
2
Congo, Democratic Republic of
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
Sri Lanka
2
Central African Republic
2
Angola
2
Indonesia
2
Ecuador
2
Myanmar / Burma
2
North Macedonia
1
Timor Leste/ East Timor
1
China
1
Cameroon
1
Burundi
1
Philippines
1
Guinea
1
Armenia
1
Tanzania
1
South–East Asia Region
1
Belgium
1
Spain
1
Belarus
1
Bolivia
1
Argentina
1
Bangladesh
1
Vietnam
1
Sudan
1
Georgia
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Countries
126
Clinical Guidelines
42
Public Health
33
Women & Child Health
22
Key Resources
17
Capacity Building
5
Pharmacy & Technologies
2
Toolboxes
Mental Health
76
COVID-19
59
TB
33
Planetary Health
31
Disability
27
Ebola
20
NCDs
20
HIV
18
Rapid Response
17
Caregiver
16
Refugee
14
Global Health Education
12
NTDs
11
AMR
11
Natural Hazards
8
Pharmacy
8
Conflict
7
Specific Hazards
4
Social Ethics
3
Zika
3
Cholera
2
Update, 23 de junio de 2022
La promotion de la santé et la prévention des maladies nécessitent une action multisectorielle qui renforce les environnements favorables à la santé et oriente les comportements. Au niveau des cantons et des communes, de nombreuses politiques, telles
la protection de la jeunesse, la promotion ...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
Lymphatic filariasis (LF) infection if untreated results in fluid accumulation in the limbs or breasts (lymphedema) or genitalia (hydrocele) that is painful and causes great discomfort. Morbidity management and disability prevention (MMDP) strategies such as surgery for hydrocele, treatment of acute...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis is a life-threatening disease and recognized as an important cause of pulmonary haemorrhage syndrom...
To better adapt current case management practices and address excess mortality in otherwise treatable
cases will require better knowledge of the demographic characteristics of the patients and comorbidities
which can make severe dehydration harder to tolerate physiologically. With this in mind, a ...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy)
and more specific interventions, such as carotid revascularization or...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
The document "Global Report on Diabetes" by the World Health Organization (WHO) provides an in-depth analysis of diabetes as a global health challenge. It covers the rising prevalence of the disease, the associated risk factors, and the increasing burden on healthcare systems, particularly in low- a...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
The Resolution Population and Individual Approaches to the Prevention and Management of Diabetes and Obesity was approved by the 48th Directing Council of the Pan American Health Organization, September 29- October 3, 2008, in response to the epidemic of obesity and diabetes currently affecting the ...
Obesity and diabetes are affecting the peoples of the Americas at high and increasing rates. National surveys demonstrate that obesity is increasing in prevalence among all age groups; 7% to 12% of children under 5 years old and
one-fi fth of adolescents are obese, while rates of overweight and obe...
